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Amajor barrier in understanding nervous system development is modeling the cellular interactions that form
the human brain. Recently, in the journal Nature, Lancaster et al. (2013) established a protocol for culturing
pluripotent stem cell (PSC)-derived ‘‘cerebral organoids’’ that mimics the developing human brain’s cellular
organization, segregates into distinct brain regions, and models microcephaly.Access to large numbers of specialized
cell types is a prerequisite for the use of
stem cells in disease modeling, drug
discovery, and regenerative medicine.
Controlling the differentiation of pluripo-
tent stem cells (PSCs) in vitro is compli-
cated by the fact that cell fate in vivo is
determined through a plethora of complex
cell-cell interactions. Protocols have been
devised to direct PSC differentiation into
specific neural cell fates using extrinsic
cues such as growth factors or small
molecules. However, differentiation re-
sponses are often difficult to control, in
part, due to cell-intrinsic signaling arising
from the in vitro cultures themselves. As
an alternative to adding or subtracting
signals during PSC differentiation, re-
searchers studying CNS development
have observed that early differentiating
neural cells spontaneously produce the
signals that are necessary and sufficient
to promote differentiated cell fates. A
recent paper from the Knoblich labora-
tory (Lancaster et al., 2013) takes this
approach to the next level by establishing
‘‘cerebral organoid’’ cultures from human
PSCs, which display a remarkable self-
organizing capacity and faithfully model
early aspects of human brain develop-
ment in 3D.
The road toward generating cerebral
organoids was sparked more than 30
years ago, when Honegger and col-
leagues dissociated rat brain tissue and
found that if cultured as cell suspensions,
they would form aggregates that con-
tained ‘‘reformed’’ brain structures (Hon-
egger et al., 1979). More recently, several
groups have made use of the self-orga-
nizing principles of mouse and human
PSCs to reproduce stages of forebrain
development including layer-specificneuron production, to form 3D optic
vesicle and optic cup structures and to
model tissue interactions during pituitary
fate specification (reviewed in Sasai,
2013). The study by Lancaster et al.
(2013) reports a method that unites and
extends those prior studies by enabling
cell aggregation in a spinning bioreactor.
Under these conditions, larger 3D struc-
tures form that contain regionalized cells
associated with multiple distinct brain re-
gions. In areas mimicking the developing
human cortex, they observed stratifica-
tion of the cells into layers marked by
expression of canonical cortex markers
such as TBR2, TBR1, Reelin, CTIP2, and
SATB2. The spinning bioreactor method
also generated larger contiguous, ventric-
ular zone-like areas and structures ex-
pressing markers of the choroid plexus,
a structure involved in producing cerebro-
spinal fluid. Interestingly, Lancaster et al.
(2013) also identified a zone of putative
outer radial glia cells (oRGs) within orga-
noids. oRGs represent a neurogenic pro-
genitor population first identified and
particularly abundant in the developing
human cortex (Hansen et al., 2010). While
oRGs are also observed during mouse
development (Wang et al., 2011), their
relative abundance is thought to corre-
late with brain size. Lancaster et al.
(2013) indeed observed fewer oRG-like
cells in matched mouse cerebral organo-
ids. Other features observed within cere-
bral organoids include hippocampal-like
areas as well as developmental bound-
aries such as the OTX2/GBX2 boundary
separating the midbrain and hindbrain
during development.
A key objective in the field is the use of
patient-specific induced PSCs (iPSCs) for
modeling genetic disease. Lancaster et al.Cell Stem Cell 1(2013) applied the organoid culture tech-
nique to study microcephaly, a neurode-
velopmental disorder resulting in small
brain size. They reprogrammed fibro-
blasts to iPSCs from a healthy control
and a patient with severe microcephaly
harboring a mutation in the CDK5RAP2
gene, a gene that binds and activates
CDK5. CDK5 mutant mice die at birth
and exhibit profound brain disorganiza-
tion including inversion of cortical layers
caused by impaired neuron migration
(Ohshima et al., 1996), and CDK5RAP2
mutations have been reported in patients
with microcephaly (Bond et al., 2005).
The mutant iPSC line grew smaller cere-
bral organoids that resulted in fewer
SOX2+ neural progenitors but a larger
percentage of neurons compared to their
control organoids, suggesting that pre-
mature differentiation of neural pro-
genitors into neurons may underlie the
disease pathology. Overexpression of
CDK5RAP2 rescued the patient-spe-
cific phenotype, restoring organoid size.
Finally, they showed that knockdown
of CDK5RAP2 in the healthy control
cells can increase Doublecortin+ cells (a
marker of young neurons) at the expense
of SOX2+ progenitor cells, phenocopying
what is observed in the patient-specific
iPSC line.
Although this report demonstrates the
feasibility of using cerebral organoid cul-
ture for modeling a neurodevelopmental
disease, there are a couple of points to
consider. How efficient is organoid gener-
ation? The lack of cell-fate quantifica-
tion makes it difficult to evaluate yield
and reproducibility of generating specific
brain regions and to determine vari-
ability across PSC lines. Careful analysis
of those parameters will be crucial for3, October 3, 2013 ª2013 Elsevier Inc. 377
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Figure 1. Prospective Strategies for Employing Cerebral Organoid Cultures
(A) Lancaster et al. (2013) established cerebral organoids of mixed composition representing multiple brain structures and regions as indicated by the different
colored circles (highlighted top panel). One potential avenue of investigation would be to direct the self-organization properties of neuralized cells toward specific
brain regions (directed organization), which may reduce variability among organoids.
(B) Combining self-organization with directed differentiation protocols may enable novel methods to study stem cells in vitro. Potential applications for such
organoids are listed.
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Other limitations include nutrient access
of cells in the center triggering cell death
and limiting overall organoid size. There-
fore, developing strategies that integrate
blood vessel growth and the formation
of meningeal structures may represent
some of the next major challenges
for this approach. Another unresolved
bottleneck in the PSC field is the slow
developmental timing of human brain
development. Cerebral organoids appear
to mimic brain development correspond-
ing to the first and possibly second
trimester of human gestation. The current
data do not fully address to what extent
the timing of neural differentiation may
be accelerated using this technique. For
example, Lancaster et al. (2013) did not
provide evidence for the presence of
late-born cells such as astrocytes and
oligodendrocytes that comprise the
majority of cells in the adult brain and
did not show conclusive markers of inter-
neuron fate, which are neurons known to
mature late during development. There-
fore, building adult-like cerebral organo-
ids remains a distant goal for the field.
Low purity and insufficient control over
cell composition may further limit the378 Cell Stem Cell 13, October 3, 2013 ª201use of the method for cell replacement
therapy or in drug discovery in which
more homogenous populations of cells
are preferred. One attractive strategy for
the future may be to combine directed
differentiation (Chambers et al., 2009)
with self-organization to further improve
efficiencies or with morphogens speci-
fying ventral midbrain or spinal cord to
model the 3D architecture of additional
brain regions.
The current study puts cerebral organo-
ids on the map as a complementary
approach to directed differentiation for
modeling human disease and other stem
cell-based applications (Figure 1). The
organoid technology will be a powerful
tool for clonal lineage tracing, fate map-
ping, and for gain- and loss-of-function
experiments as an alternative to human
embryo brain slice cultures. Transplanta-
tion of defined cell types into organoids
is also an attractive option to study
cell fate potential, migration, and syn-
aptic integration as well as cross-
species developmental timing by intro-
ducing mouse cells into human organoids
and vice versa. The quantum phys-
icist Richard Feynman famously wrote,
‘‘What I cannot create, I do not under-3 Elsevier Inc.stand.’’ While there is still a long road
ahead, the study by Lancaster et al.
(2013) suggests that efforts aimed at
creating a ‘‘brain in a dish’’ could become
a valuable tool in understanding human
brain function.
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